Articles with public access mandates - Antonio BarbieriLearn more
Not available anywhere: 3
Cardiotoxicity and pro-inflammatory effects of the immune checkpoint inhibitor Pembrolizumab associated to Trastuzumab
V Quagliariello, M Passariello, C Coppola, D Rea, A Barbieri, M Scherillo, ...
International Journal of Cardiology 292, 171-179, 2019
Mandates: Government of Italy
Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancer
G Palma, C Conte, A Barbieri, S Bimonte, A Luciano, D Rea, F Ungaro, ...
International journal of pharmaceutics 473 (1-2), 55-63, 2014
Mandates: Government of Italy
Novel peptide-based PET probe for non-invasive imaging of CXC chemokine receptor type 4 (CXCR4) in tumors
AM Trotta, M Aurilio, C D’Alterio, C Ierano, D Di Martino, A Barbieri, ...
Journal of Medicinal Chemistry 64 (6), 3449-3461, 2021
Mandates: Government of Italy
Available somewhere: 37
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
V Quagliariello, M De Laurentiis, D Rea, A Barbieri, MG Monti, A Carbone, ...
Cardiovascular diabetology 20, 1-20, 2021
Mandates: Government of Italy
Microbiota effects on cancer: from risks to therapies
D Rea, G Coppola, G Palma, A Barbieri, A Luciano, P Del Prete, ...
Oncotarget 9 (25), 17915, 2018
Mandates: Government of Italy
A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo
L Mele, F Paino, F Papaccio, T Regad, D Boocock, P Stiuso, A Lombardi, ...
Cell death & disease 9 (5), 572, 2018
Mandates: Government of Italy
Sex‐and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry
M Lainščak, I Milinković, M Polovina, MG Crespo‐Leiro, LH Lund, ...
European journal of heart failure 22 (1), 92-102, 2020
Mandates: Ministry of Education, Science and Technological Development of the Republic …
Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastases
L Portella, R Vitale, S De Luca, C D’Alterio, C Ierano, M Napolitano, ...
PloS one 8 (9), e74548, 2013
Mandates: Government of Italy
Management of QT prolongation induced by anti-cancer drugs: target therapy and old agents. Different algorithms for different drugs
C Coppola, A Rienzo, G Piscopo, A Barbieri, C Arra, N Maurea
Cancer treatment reviews 63, 135-143, 2018
Mandates: Government of Italy
Hmga1/Hmga2 double knock-out mice display a “superpygmy” phenotype
A Federico, F Forzati, F Esposito, C Arra, G Palma, A Barbieri, D Palmieri, ...
Biology open 3 (5), 372-378, 2014
Mandates: Government of Italy
Mouse models in prostate cancer translational research: from xenograft to PDX
D Rea, V Del Vecchio, G Palma, A Barbieri, M Falco, A Luciano, ...
BioMed research international 2016 (1), 9750795, 2016
Mandates: Government of Italy
Evidences of CTLA-4 and PD-1 blocking agents-induced cardiotoxicity in cellular and preclinical models
V Quagliariello, M Passariello, D Rea, A Barbieri, M Iovine, A Bonelli, ...
Journal of Personalized Medicine 10 (4), 179, 2020
Mandates: Government of Italy
Can beta-2-adrenergic pathway be a new target to combat Sars-Cov-2 hyperinflammatory syndrome?—lessons learned from cancer
A Barbieri, N Robinson, G Palma, N Maurea, V Desiderio, G Botti
Frontiers in immunology 11, 588724, 2020
Mandates: Government of Italy
The anti-apoptotic BAG3 protein is expressed in lung carcinomas and regulates small cell lung carcinoma (SCLC) tumor growth
G Chiappetta, A Basile, A Barbieri, A Falco, A Rosati, M Festa, ...
Oncotarget 5 (16), 6846, 2014
Mandates: Government of Italy
Cancer-associated CD43 glycoforms as target of immunotherapy
FM Tuccillo, C Palmieri, G Fiume, A De Laurentiis, M Schiavone, ...
Molecular cancer therapeutics 13 (3), 752-762, 2014
Mandates: US National Institutes of Health, Government of Italy
In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies
C Ieranò, D Righelli, C D'Alterio, M Napolitano, L Portella, G Rea, ...
Journal for immunotherapy of cancer 10 (3), 2022
Mandates: AIRC Foundation for Cancer Research in Italy
Role of viral miRNAs and epigenetic modifications in Epstein‐Barr virus‐associated gastric carcinogenesis
A Giudice, G D’Arena, A Crispo, MF Tecce, F Nocerino, M Grimaldi, ...
Oxidative medicine and cellular longevity 2016 (1), 6021934, 2016
Mandates: US National Institutes of Health
The effects of naloxone on human breast cancer progression: in vitro and in vivo studies on MDA. MB231 cells
S Bimonte, A Barbieri, M Cascella, D Rea, G Palma, V Del Vecchio, ...
OncoTargets and therapy, 185-191, 2018
Mandates: US National Institutes of Health
Strain analysis in the assessment of a mouse model of cardiotoxicity due to chemotherapy: sample for preclinical research
D Rea, C Coppola, A Barbieri, MG Monti, G Misso, G Palma, S Bimonte, ...
in vivo 30 (3), 279-290, 2016
Mandates: Government of Italy
Cardiotoxic effects of the novel approved anti-ErbB2 agents and reverse cardioprotective effects of ranolazine
C De Lorenzo, R Paciello, G Riccio, D Rea, A Barbieri, C Coppola, ...
OncoTargets and therapy, 2241-2250, 2018
Mandates: Government of Italy
Publication and funding information is determined automatically by a computer program